BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 3327120)

  • 21. ACE inhibitors or inotropic drugs after diuretics in heart failure--a personal critique.
    Ikram H; Nicholls MG; Fitzpatrick MA; Crozier IG
    Postgrad Med J; 1986; 62 Suppl 1():176-8. PubMed ID: 3534858
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What is new in the medical management of acute heart failure?].
    Meyer P; White M; Keller RF; Lerch R; Hullin R
    Rev Med Suisse; 2010 Jun; 6(252):1211-7. PubMed ID: 20614757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiac insufficiency in childhood].
    Atik E
    Arq Bras Cardiol; 1979 Nov; 33(5):359-68. PubMed ID: 399175
    [No Abstract]   [Full Text] [Related]  

  • 25. [Highlights from a symposium on the treatment of heart failure].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):257-61. PubMed ID: 6544207
    [No Abstract]   [Full Text] [Related]  

  • 26. [First-line treatment of cardiac insufficiency: digitalis glycosides, diuretics, vasodilator agents or new cardiotonic agents?].
    Komajda M; Lechat P; Grosgogeat Y
    Presse Med; 1988 Apr; 17(15):747-50. PubMed ID: 2968553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiological bases and treatment of cardiac decompensation].
    Westerhof PW; Meursing BT
    Ned Tijdschr Geneeskd; 1989 Jun; 133(24):1206-10. PubMed ID: 2568589
    [No Abstract]   [Full Text] [Related]  

  • 29. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.
    Schubert S; Peters B; Abdul-Khaliq H; Nagdyman N; Lange PE; Ewert P
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):333-7. PubMed ID: 15736252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic effects of ARL 115 in left ventricular insufficiency].
    Drobinski G; Komajda M; Lechat P
    Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):475-9. PubMed ID: 6508198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of resistant cardiac failure; vasodilators and new inotropic drugs].
    Herziano H; Gil I; Almog C
    Harefuah; 1980 Jun; 98(11-12):517-8. PubMed ID: 7203196
    [No Abstract]   [Full Text] [Related]  

  • 35. Current management of congestive heart failure in infants and children.
    Kohr LM; O'Brien P
    Nurs Clin North Am; 1995 Jun; 30(2):261-90. PubMed ID: 7777408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective management of congestive cardiomyopathy. Relation to ventricular structure and function.
    Spodick DH
    Arch Intern Med; 1982 Apr; 142(4):689-92. PubMed ID: 6122431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic therapies for acutely decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S18-27. PubMed ID: 12439427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug therapy for congestive heart failure poses several risks during dental treatment.
    Biron CR
    RDH; 1996 Feb; 16(2):46-8, 50, 64. PubMed ID: 9442754
    [No Abstract]   [Full Text] [Related]  

  • 39. [Principles of the treatment of myocardial failure].
    Korewicki J; Rajecka A; Madeja G
    Kardiol Pol; 1990 Feb; 33(2):126-35. PubMed ID: 2277484
    [No Abstract]   [Full Text] [Related]  

  • 40. [New inotropic vasodilators: what is their role in the long-term treatment of heart failure?].
    Padrini R
    G Ital Cardiol; 1987 Mar; 17(3):259-63. PubMed ID: 3301506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.